Enzymes and chemicals
All chemicals, catalase (from bovine liver) and lysozyme (from chicken egg) were obtained from Sigma Aldrich (Steinheim, Germany) unless otherwise stated.
The plasmid for expression of GO-LOX enzyme was a kind gift from Prof. Ping Xu and Dr. Chao Gao (Shandong University, China). The pDB-HisGST plasmid used for cloning of P450 SPα was obtained from the DNASU plasmid repository.
[1]
1.2. Biocatalysts 1.2.1. Cloning, expression and purification of P450 CLA (in-house number pEG306)
Cloning of P450 CLA from Clostridium acetobutylicum [2] was performed as reported elsewhere. [3] For heterologous expression, cells were grown overnight (140 rpm, 37 °C) in a 50 mL shake flask as preculture in 10 mL lysogeny broth (LB) medium supplemented with 50 µg/mL kanamycin. For preparing the main culture, 1 mL of grown pre-culture was transferred into 100 mL TB medium pre-filled into a 1 L shake flask supplemented with 50 µg/mL kanamycin and 100 µL of a sterile filtered trace elements solution [4] and incubated at 140 rpm and 37 °C. At an optical density (OD 600 ) of 0.8, the expression was induced by adding 100 µL of 100 mM IPTG solution (isopropyl β-D-1-thiogalactopyranoside) and 200 µL of 0.5 M δ-aminolevulinic acid (ALA) solution. After incubation for 20 h at 25 °C, the cells were centrifuged for 15 min at 3,000 x g and 4 °C. The supernatant was discarded and the pellet was frozen at -20 °C. Frozen cell pellets were resuspended in 20 mL purification buffer A (KPi, 100 mM, pH 7.0, 20% glycerol, 300 mM KCl and 50 mM imidazole). Lysozyme was added (1 mg/mL) followed by incubation at 37 °C for 2 h. Cells were finally disrupted by sonication (1 min at 30% amplitude; 2 sec on, 4 sec off, Digital Cell Disrupter, Branson, Emerson Electric). Cell debris was removed by ultracentrifugation (23,500 x g, 20 min, 4 °C). The cell free lysates were pressed through a sterile 0.45 µm Rotilabo® syringe filter (Roth, Karlsruhe, Germany) to eliminate residual particles.
Filtered cell free lysates were purified by a 5 mL His-Trap TM FF column (GE Healthcare Europe GmbH), which was washed with 50 mL water. For eluting the undesired enzymes, the column was washed with 50 mL (10 column volumes) of buffer A (without glycerol). After the washing step, P450 CLA was eluted by buffer B (KPi, 100 mM, pH 7.0, 300 mM KCl and 400 mM imidazole) and the fraction containing P450 CLA (~20 to 30 mL) was dialyzed for 36 h with imidazole-free buffer C (KPi, 100 mM, pH 7.0, 300 mM KCl) to remove residual imidazole using a dialysis tubing cellulose membrane (14 kDa cutoff, Sigma Aldrich, Steinheim, Germany). The purified protein was dialyzed three times against 300 mL buffer C (3 x 12 h) at 4
°C under continuous and slow stirring (50 rpm). Both activity and concentration of the enzyme were measured via analysis of reduced CO difference spectra as published by Omura and Sato. [5] Upon addition of 300 mM KCl, no visible precipitation occurred during the entire dialysis procedure and active P450
concentrations between 10 to 20 µM were regularly obtained without further concentration steps. 
Expression and purification of GO-LOX [(R)-α-HAO] (in-house number pEG359)
The plasmid for expression of GO-LOX enzyme from Gluconobacter oxydans 621H was a kind gift from Prof. Ping Xu and Dr. Chao Gao (Shandong University, China). [6] The plasmid was transformed into E. coli BL21 (DE3) and one colony was used to grow a new pre-culture in 10 mL LB medium containing 100 µg/mL ampicillin. For preparing the main culture, 1 mL of grown preculture was transferred into 100 mL LB medium pre-filled into a 1 L shake flask supplemented with 100 µg/mL ampicillin solution and incubated at 140 rpm and 37 °C. At an optical density (OD 600 ) of 0.4-0.6, the expression was induced by adding 1 mM IPTG solution and incubation was carried out at 16 °C for further 10 h. Cells were harvested, washed and disrupted by sonication (amplitude 20%, 6 sec on, 6 sec off, total time 15 min) in binding buffer (pH 7.4, 20 mM sodium phosphate, 500 mM NaCl and 20 mM imidazole)
supplemented with 1 mM phenylmethylsulfonyl fluoride (PMSF) and 10% glycerol.
After centrifugation (15 min at 23,500 x g and 4 °C), the resulting supernatant was loaded onto a HisTrap HP column (5 mL) equilibrated with binding buffer (pH 7.4, 20 mM sodium phosphate, 500 mM NaCl and 20 mM imidazole), and eluted with elution buffer (20 mM NaPi, pH 7.4, 500 mM NaCl and 500 mM imidazole)
to obtain the purified target enzyme ( Figure S1 ). The purified enzyme was finally concentrated by (S)-α-HAO [7] is a FMN-dependent and (S)-specific α-hydroxyacid oxidase from A. viridans. The gene coding for the protein bearing mutation A95G was ordered (Thermo Fisher Scientific) and cloned in pET28a(+) using restriction sites XhoI and NdeI such that the protein bears a His6-tag. 
TTTGATAATCCGTATGGCTATGAGTATTAA
For over-expression, 10 mL of autoclaved TB medium was filled in a 50 mL shake flask supplemented with 50 µg/mL kanamycin solution and 10 µL glycerol stock solution, then incubated overnight at 140 rpm and 37 °C. 1 mL of the pre-culture was transferred into 100 mL TB medium pre-filled into a 1 L shake flask supplemented with 50 µg/mL kanamycin solution incubated at 140 rpm and 37 °C. At an optical density (OD 600 ) of 1, the expression was induced by adding 100 µL of 500 mM IPTG solution. After incubation for 20 h at 30 °C, the cells were centrifuged for 15 min at 3,000 x g and 4 °C. The supernatant was discarded and the pellet was frozen at -20 °C until further use. Frozen cell pellets were re-suspended in 20 mL lysis buffer (KPi, 50 mM, pH 7.5, 50 mM imidazole and 1 mg/mL lysozyme) followed by incubation on ice for 2 h.
Before sonication, FMN (10 µM final concentration) was added, then cells were disrupted by sonication (Amplitude 20%, 4 sec on, 4 sec off, total time 5 min). Cell debris was removed by ultracentrifugation (14,000 x g, 20 min, 4 °C). The cell free lysates were pressed through a sterile 0.45 µm syringe filter to eliminate residual particles. Filtered cell free lysates were purified by a 5 mL His-Trap TM FF column (GE Healthcare Europe GmbH), which was washed with 50 mL water. For eluting the undesired enzymes, the column was washed with 50 mL (10 column volumes) binding buffer (KPi, 50 mM, pH 7.5, 20 mM imidazole). After the washing step, the target enzyme was eluted with the elution buffer (KPi, 50 mM, pH 7.5, 400 mM imidazole) and stored in buffer (KPi, 50 mM, pH 7.5, 50 mM KCl) by using a desalting column (PD-10 Desalting Column, GE Healthcare). In order to confirm purity, all samples were loaded on 10 % SDS-PAGE ( Figure S2 ). Oxidase activity was measured at room temperature using a peroxidase-coupled assay containing 3,5-dichloro-2-hydroxybenzenesulfonic acid (DCHBS) and 4-aminoantipyrine (AAP) as chromogenic substrates (HRP-AAP/DCHBS assay) in combination with lactic acid as substrate. [8] The oxidation of lactic acid by (S)-α-HAO releases H 2 O 2 , which is monitored by the assay.
Assay mixture composition: 200 µL of 0.1 mM AAP and 1 mM DCHBS, 20 µL of 5 mg/mL HRP, 10 µL of 100 mM substrate (rac-lactic acid), 680 µL phosphate buffer (100 mM, pH 7). 50 µL cell lysate containing (S)-α-HAO was added directly before measuring absorption at 515 nm.
FMN was added to all reaction mixtures to allow full saturation of the enzyme following purification.
Cloning, expression and purification P450 SPα from Sphingomonas paucimobilis (in-house number pEG371)
The pDB-HisGST vector harboring a GST-tag (fusion protein to enhance soluble expression) followed by a N-terminal His 6 -tag was chosen as expression vector.
[1] Additionally, this vector gives the ability to cleave off the GST-tag by a TEV protease. The gene coding for P450 SPα [9] was ordered from Thermo Fisher Scientific (Germany) and inserted into pDB-HisGST vector using NdeI and XhoI restriction sites. ONCs of the transformants were prepared in 50 mL tubes (10 mL LB Medium + 50 µg/mL kanamycin) and incubated at 37 °C and shaken at 120 rpm overnight. ONCs were used to prepare glycerol stocks (500 µL culture + 500 µL 30% glycerol stock) and stored until further use (at -20 °C or -80 °C).
For growing cells, shaking flasks (volume 250 mL or 1 L) were filled with TB medium (100 mL or 330 mL) and autoclaved. After cooling to room temperature, kanamycin (50 µg/mL) and 100 µL of a sterile filtered trace elements solution [4] were added. The prepared medium was inoculated with the ONC (1 mL) and shaken at 37 °C and 120 rpm. When OD 600 reached 0.6 -0.8, the cultures were cooled down to room temperature and -aminolevulinic acid was added (0.5 mM). Cells were then induced with IPTG (0.1 mM) and the culture was shaken overnight at 20 °C and 120 rpm. The next day the cells were harvested by centrifugation (12,040 x g, 20 min, 4 °C). The cell pellets were washed with buffer (KPi, 100 mM, pH 7.4, 10 mL buffer per g pellet used) and resuspended in the same buffer (if His-tag purification was performed, lysis buffer B was used). For cell disruption, the suspension was ultrasonicated on ice [(30% amplitude, 2 sec on, 4 sec off for 2 min) x 2]. Cell debris was removed by centrifugation (18,800 x g, for 20 min, at 4 °C) and the supernatant (soluble fraction) was used for enzyme purification. The pellet was resuspended in buffer B (KPi, 100 mM, pH 7.5, 100 mM NaCl, 0.8% w/v cholate, 1 mM PMSF and 15% v/v glycerol, 10 mL buffer per g pellet used) and a sample was taken (insoluble fraction). Expression level of the enzyme was analyzed by SDS-PAGE ( Figure S3 ). Both activity and concentration of the enzyme were measured via analysis of reduced CO difference spectra as published. To purify the N-terminal His-tagged GST-fused SPα enzyme, a 5 mL His-Trap TM FF column (GE Healthcare Europe GmbH) was used. After harvesting the cells, the pellets obtained from centrifugation (12,040 x g at 4 °C for 20 min) were washed with buffer (KPi, 100 mM, pH 7.4) and resuspended in lysis buffer (KPi, 100 mM, pH 7.5, 100 mM NaCl, 0.8% w/v cholate, 1 mM PMSF, 30 mM imidazole and 15% v/v glycerol, 10 mL lysis buffer per g cell pellet used) and incubated for 2 h. The suspension was ultrasonicated [(30% amplitude, 2 sec on, 4 sec off for 2 min) x 2] and centrifuged again (38,800 x g at 4 °C for 20 min). The column was washed with lysis buffer (50 mL). Then, the sterile filtered sample (0.45 µm Rotilabo® syringe filter) was loaded onto the column and washed again with lysis buffer (50 mL). Enzyme was eluted with elution buffer (KPi, 100 mM, pH 7.5, containing 100 mM NaCl, 0.8% w/v cholate, 1 mM PMSF, 250 mM imidazole and 15% v/v glycerol, up to 25 mL). Eluted fractions were concentrated by centrifugation in VIVASPIN tubes (MWCO 10 kDa, 4,688 x g at 4 °C).
After concentration, samples were desalted (PD-10 Desalting Columns, GE Healthcare) and eluted in buffer (KPi, 100 mM, pH 7.4 containing 15% glycerol) and stored at 4 °C. Glycerol was removed from the enzyme solution before use in biotransformations by using centrifugation in VIVASPIN tubes (MWCO 10 kDa, 4,688 x g at 4 °C) and loading fresh reaction buffer (KPi, 100 mM, pH 7.4). The purified sample was cleaved with TEV protease. [1a] SDS-PAGE results during loading, after purification and after cleavage of the enzyme are shown in Figure S4 . Most of the protein bound to the column and was eluted afterwards (P -pure fraction around 75 kDa). After TEV protease (27 kDa) addition, successful cleavage was monitored (P450 SPα at 40 kDa and GST-tag at 25 kDa).
Activity assay of purified enzymes

GO-LOX and (S)--HAO
The oxidase activity of both purified hydroxyacid oxidases (GO-LOX and (S)--HAO) was tested in the oxidation of rac-2-hydroxyoctanoic acid (2) (Scheme S1-S2). Initial oxidation reactions were performed in 1 mL scale in closed glass vials at 170 rpm for 24 h. Analysis on GC-GC/MS was performed after extraction and derivatization as reported below (1.4.3). Dodecanoic acid (5 mM) was used as internal standard.
In both reactions, ethanol was used as co-solvent. It is a co-solvent of choice for fatty acid-type substrates [3] and is not accepted by the two hydroacid oxidases, which are highly specific for 2-hydroxy acid substrates. The reaction was performed in 1 mL buffer (KPi, 100 mM, pH 7.4) containing 5 μM P450 CLA , 10 mM The reaction was performed in 1 mL buffer (KPi, 100 mM, pH 7.4), containing 5 μM P450 SPα (GST-tagged enzyme), 10 mM octanoic acid, 10 % EtOH (co-solvent), 0.1 mM FMN, 1.0 mg/mL (S)--HAO and H 2 O 2 at varying concentrations (0.5 mM to 3 mM). Cascade reactions were performed in duplicates in closed glassvials at RT and 170 rpm for 24 h.
General procedure for extraction and derivatization on GC-GC/MS
Analysis on GC-GC/MS was performed after extraction and derivatization. Dodecanoic acid (5 mM) was employed as internal standard. Silylation was found to be the most suitable derivatization method before achiral GC and GC-MS analysis (leading to quantitative yield to corresponding silylated substrate, hydroxy and oxo-products). Silylation of final oxo-product delivered a mixture of derivatized oxo-acid and derivatized enol-form of the oxo-acid.
To this end, 100 μL of 5 M HCl were added to 1 mL aqueous buffer solution (blank or enzymatic reaction mixture or standard) before extraction with EtOAc (2 x 0.5 mL) containing 5 mM dodecanoic acid as internal standard. The combined organic phases were dried over Na 2 SO 4 . After centrifugation for 1 min, 100 μL were sampled and mixed with 200 μL of 1:1 (BSTFA/TMCS 99:1 -N,OBistrifluoroacetamide/trimethylsilylchloride)/pyridine solution. After 2 hours at room temperature, samples were directly analyzed on GC-GC/MS.
Results and discussion
Stability of 2-oxooctanoic acid (3) in presence of hydrogen peroxide
Non-enzymatic H 2 O 2 -mediated oxidative decarboxylation [10] of 3 may reduce the apparent yield of the reaction, thereby producing heptanoic acid as side-product. In order to investigate the H 2 O 2 -recycling cascade, initial experiments focused on stability of 2-oxooctanoic acid (3) in presence of H 2 O 2 . First, decarboxylation of the ketoacid by H 2 O 2 was investigated on a mixture of 10 mM 3 and 5 % EtOH (cosolvent) in buffer (KPi, 100 mM, pH 7.5, 1 mL) in closed glass vials at RT and 170 rpm. H 2 O 2 was added at a final concentration of 0.4, 0.8, 1.6 or 3.2 mM. BSA (5µM) was added to a second series of reactions to investigate the possible effect of protein surface catalyzed decarboxylation of 2-ketoacid. 200 µL from each mixture was taken at four time points (30 min, 1 h, 2 h and 4 h). A calibration curve was prepared using commercially available 2-oxooctanoic acid and GC-MS analytics.
In absence of BSA, decarboxylation of 2-oxooctanoic acid occurred, mostly at higher concentration of peroxide (>3 mM). In presence of BSA, decarboxylation was more pronounced and more advanced at higher concentrations of H 2 O 2 (1.6 and 3.2 mM). At 10 mM H 2 O 2 decarboxylation was nearly complete (Table S1 ). 
Activity assay for purified enzymes
GO-LOX and (S)-α-HAO
The oxidase activity of purified hydroxyacid oxidases (GO-LOX and (S)-α-HAO) was tested in the oxidation of rac-2-hydroxyoctanoic acid (2) (Scheme S1 
P450 SPα (GST-tagged and cleaved-tag preparations)
Hydroxylation ability of purified P450 SPα (the tagged enzyme and the enzyme preparation containing the free protein with the cleaved tag in solution) was tested on 10 mM 1 in presence of 3.0 mM H 2 O 2 . Results are shown in Table S2 and Figure S6 . Both enzyme preparations were tested in the cascade set-up B in combination with (S)--HAO ( Figure S7 ). Detailed methods are provided in section 3. Only small differences between both systems could be observed due to the removal of the tag, confirming the functional activity of the protein in both preparations and indicating that the presence of the free tag in solution was not responsible for side activities.
Testing cascades A and B
Conversion of octanoic acid (1) to 2-oxooctanoic acid (3) with P450 CLA /(S)--HAO
A test cascade was performed on octanoic acid (1) using two enzymes in a one-pot cascade consisting of (Table S3 ). Successful formation of final oxo-product 3 after 12 h could be confirmed in all samples where H 2 O 2 and both enzymes were present (entries 1-5, Table S3 ).
Despite some variations in the recovery (attributed to analytical error), the amount of product 3 obtained from 3.2 mM H 2 O 2 corresponds to the expected theoretical value (measured 7.3 mM, with 6.8 mM corresponding to complete H 2 O 2 -recycling) with maximum allowed formation of (R)-2 (3.3 mM). In the absence of (S)--HAO, P450 CLA could efficiently and regioselectively hydroxylate octanoic acid and the amount of 2 formed equaled the maximum theoretical concentration that can be reached under these conditions (i.e. same as concentration of oxidant used, entry 8, Table S3 ). In the cascade set-up and independent on the amount of oxidant used, the amount of recovered intermediate 2 was found to correlate with the amount of oxidant used (entries 1-4, Table S3 ). This, together with the rather steady ratio 2/3 ( Table   S3 ), confirms that both steps have reached maximum product levels after 12 h (ratio 2/3 close to theoretical 32:68). This was confirmed by calculating ee values for 2 after 15 h reaction time: starting from 10 mM 1 and 3.2 mM oxidant, (R)-2 was obtained in 88% ee (83% starting from 0.5 mM oxidant), indicating only minor amount of residual (S)-2 in the cascade reaction mixture (only low amount of (S)--HAO used), thus corroborating that the oxidation step of (S)-2 was close to completion.
Testing cascade A by using P450 CLA /GO-LOX/(S)--HAO
Testing different concentrations of P450 CLA
Cascade A was performed with different P450 CLA concentrations under the following conditions: 1 mL buffer (KPi, 100 mM, pH 7.4) containing 10 mM octanoic acid, 10 % EtOH (co-solvent), 0.1 mM FMN, 0.5 mg/mL (S)-α-HAO, 2.0 mg/mL GO-LOX, P450 CLA (5-10 µM) and 1.0 mM H 2 O 2 . Reactions were performed in duplicates in closed glass-vials at RT and 170 rpm for 24 h and 48 h (Table S4) . Table S4 . Conversion of 1 to 3 by using various P450 CLA concentrations in the presence of 1.0 mM H 2 O 2
Testing different concentrations of GO-LOX
The effect of GO-LOX concentration was tested in cascade A using following reaction conditions: 1 mL buffer (KPi, 100 mM, pH 7.4) containing 10 mM octanoic acid, 10 % EtOH, 0.1 mM FMN, 0.5 mg/mL (S)-α-HAO, GO-LOX (0.2, 0.5, 1.0 and 2.0 mg/mL), 5 µM P450 CLA and 3.0 mM H 2 O 2 . Reactions were performed in closed glass-vials at RT and 170 rpm for 24 h (Table S5) . Temperature effects were tested by performing cascade A under the following conditions: 1 mL buffer (KPi, 100 mM, pH 7.4) containing 10 mM octanoic acid, 10 % EtOH (co-solvent), 0.1 mM FMN, 0.5 mg/mL (S)-α-HAO, 0.2 mg/mL GO-LOX, 5 µM P450 CLA and H 2 O 2 at varying concentrations (0.2 and 0.5 mM).
Cascade reactions were performed in closed glass-vials at 4 ºC and 170 rpm shaking for 24 h and 48 h (Table   S6) . Table S6 . Conversion of octanoic acid (1) to 2-oxooctanoic acid (3) by using 0.2 mg/mL GO-LOX in the presence of 0.2 or 0.5 mM H 2 O 2 at 4 ºC, compared to data obtained at room temperature (TON) Results reveal that higher conversions were achieved at room temperature compared to 4 ºC and, as expected by using higher H 2 O 2 concentration, higher conversions were achieved at 0.5 mM.
In addition to room temperature and 4 ºC, the cascade was performed at 30 ºC as well. Due to enzyme inactivation at this temperature, no conversion was observed in all tested conditions.
Testing cascade B by using P450 SPα /(S)-α-HAO
Cascade B was tested with different concentrations of P450 SPα using following reaction conditions: 1 mL buffer (KPi, 100 mM, pH 7.4) containing 10 mM octanoic acid, 10 % EtOH (co-solvent), 0.1 mM FMN, 1.0 mg/mL (S)-α-HAO, P450 SPα (3-10 µM) and 1.0 mM H 2 O 2 . Cascade reactions were performed in closed glass-vials at RT and 170 rpm shaking for 24 h (Table S7) . (Table S8) . Cascade reactions were performed in duplicates in closed glass-vials at room temperature and 170 rpm for 24 h. Work-up consisted in acidification with 5 M HCl (100 µL) followed by extraction with ethyl acetate (2 x 0.5 mL) spiked with dodecanoic acid (5 mM) as internal standard.
Derivatization for GC and GC-MS analysis was performed by silylation of the organic phase using BSTFA ( Figure S16-S35 ). Calibration curves were generated using standards of the substrates. For all tested substrates (C6:0, C7:0 and C10:0), 2-ketoacid products were detected as sole products, and thus conversions were calculated based on substrate consumption. GC and GC-MS chromatograms ( Figure S16 -S35) show formation of the final 2-ketoacids products in each case, detected as the corresponding silylated derivatives. The results reveal that both cascade set-ups accept other substrates with moderate to high conversion level (cascades not optimized). As the chain length of the substrate increases, higher conversions are achieved by using the cascade set-up B (two-enzyme). For shorter substrates (C6:0 and C7:0), the threeenzyme set-up appears more suited. In summary, the internal H 2 O 2 recycling protocol is applicable to a variety of fatty acids.
Analytical methods
GC, GC-MS and NMR
Silylation was found to be the most suitable derivatization method (quantitative yield to corresponding silylated substrate, hydroxy-and oxo-products). Silylation of final oxo-product delivered a mixture of derivatized oxo-acid and derivatized enol-form of the oxo-acid ( Figure S8 ). final product is therefore possible (no individual standard available for the enol form and likely different response factors for both forms). C-NMR spectra were recorded using a Bruker AVANCE III 300 MHz spectrometer using a 5mm BBO probe at 300 K. Chemical shifts () are given in parts per million (ppm) relative to TMS (δ = 0 ppm) or to the residual solvent signal, and coupling constants (J) are reported in Hertz (Hz).
Determination of ee value of 2-hydroxyoctanoic acid on chiral GC
Derivatization using ethyl chloroformate/methanol was employed using the following procedure: Reaction samples (1 mL) were shock-frozen and lyophilized, the resulting residue was taken up in 700 μL MeOH containing 5% DMAP, and 150 μL ethyl chloroformate was added. The reaction was performed at 50 °C and 700 rpm for 1 h. After solvent removal (speedvac or air flow), 700 μL of 2% aq. HCl was added and extraction was performed with EtOAc (2 x 500 μL). After drying of the combined organic phases over Figure S9 . Achiral GC chromatogram of derivatized octanoic acid 1 (internal standard dodecanoic acid with t ret 11.4 min) Figure S10 . Achiral GC chromatogram of derivatized 2-hydroxyoctanoic acid 2 (internal standard dodecanoic acid with t ret 11.4 min) Figure S11 . Achiral GC chromatogram of derivatized 2-oxo octanoic acid 3 (internal standard dodecanoic acid with t ret 11.4 min) Figure S12 . Achiral GC chromatogram obtained from cascade A using 3.0 mM H 2 O 2 as described in Table 1 of main text (internal standard dodecanoic acid with t ret 11.4 min) Figure S13 . 1 H-NMR of 2-oxo octanoic acid (3) obtained from the upscaling of cascade A (triplet at δ 2.37 ppm is related to residual substrate) Figure S14 .
GC/ GC-MS chromatograms and NMRs
1 H-NMR of 2-oxo octanoic acid (3) obtained from the upscaling of cascade B (triplet at δ 2.38 ppm is related to residual substrate) Figure S15 .
13 C-NMR of 2-oxo octanoic acid (3) obtained from the upscaling of cascade B Figure S16 . 1 H-NMR of 2-oxo octanoic acid purchased from Sigma as ≥99% purity sample. Figure S19 . GC-MS chromatogram obtained from cascade A using 3.0 mM H 2 O 2 and hexanoic acid as substrate (as described in Table S8 , entry 2) with dodecanoic acid (t ret 10.3 min) as internal standard Figure S22 . Achiral GC chromatogram of derivatized hexanoic acid with dodecanoic acid (t ret 11.3 min) as internal standard Figure S23 . Achiral GC chromatogram obtained from cascade A using 3.0 mM H 2 O 2 and hexanoic acid as substrate (as described in Table S8 , entry 2) with dodecanoic acid (t ret 11.3 min) as internal standard Figure S24 . Achiral GC chromatogram obtained from cascade B using 3.0 mM H 2 O 2 and hexanoic acid as substrate (as described in Table S8 , entry 2) with dodecanoic acid (t ret 11.3 min) as internal standard Figure S25 . GC-MS chromatogram of derivatized heptanoic acid with dodecanoic acid (t ret 10.3 min) as internal standard Figure S26 . GC-MS chromatogram obtained from cascade A using 1.0+1.0 mM H 2 O 2 and heptanoic acid as substrate (as described in Table S8 , entry 3) with dodecanoic acid (t ret 10.3 min) as internal standard . Achiral GC chromatogram obtained from cascade A using 3.0 mM H 2 O 2 and heptanoic acid as substrate (as described in Table S8 , entry 4) Figure S31 . Achiral GC chromatogram obtained from hydroxylation step of the cascade A using 3.0 mM H 2 O 2 and heptanoic acid as substrate Figure S32 . GC-MS chromatogram obtained from cascade A using 3.0 mM H 2 O 2 and decanoic acid as substrate (as described in Table S8 , entry 6) with dodecanoic acid (t ret 10.3 min) as internal standard . Achiral GC chromatogram obtained from cascade A using 3.0 mM H 2 O 2 and decanoic acid as substrate (as described in Table S8 , entry 6) with dodecanoic acid (t ret 11.3 min) as internal standard Figure S37 . Achiral GC chromatogram obtained from cascade B using 1.0+1.0 mM H 2 O 2 and decanoic acid as substrate (as described in Table S8 , entry 5) with dodecanoic acid (t ret 11.3 min) as internal standard
